Key result
Aggressive immunosuppression restores LVEF to 73% in a case of lupus myocarditis.
Why the study?
Lupus myocarditis is a rare, life-threatening manifestation of SLE that can rarely occur as the initial presentation of the disease.
Case Report (n=1)
Prompt recognition and aggressive immunosuppressive treatment of lupus myocarditis presenting as acute heart failure can lead to a favorable prognosis and full recovery of cardiac function.
May inform acute lupus myocarditis management; hypothesis-generating and should not yet change practice.
Lupus myocarditis (LM) is a rare but potentially life threatening manifestation of systemic lupus erythematous (SLE). LM may be rarely the initial presentation of SLE or ma y be presented during the course of the disease. Herein, we report a case of an adult female patient who presented with a 3-day history of abdominal pain, fever and recent onset dyspnea on exertion. Twenty-four hours later the patient developed acute heart failure went into cardiac arrest during her transfer from the internal medicine department to the CT scanner. She was intubated, an intra-aortic balloon pump was inserted, and was transferred to the intensive care unit (ICU). Based on clinical signs, laboratory parameters and cardiac imaging and after the exclusion of other causes of acute heart failure LM was diagnosed. The patient received high doses of corticosteroids and cyclophosphamide and she was improved. The vasopressors were tapered off and the intra-aortic balloon pump was removed. The patient improved and she shifted out of the ICU. The initially increased t roponin levels were decreased, while the ejection fraction increased to 60% five days later. The patient was followed as an outpatient after hospital discharge. At 6 months of follow-up the she was on treatment with low doses of oral steroids, hydroxychloroquine and azathioprine and her ejection fraction is 73% without signs of active disease. No recurrences of her LM have been observed during her 32 month follow-up. Prompt recognition and aggressive immunosuppressive treatment may lead to favourable prognosis.
No takes yet. Share an insight, caveat, or question.
Staveri et al. (2026) conducted a case report in Lupus myocarditis as initial presentation of SLE (n=1). Corticosteroids and cyclophosphamide was evaluated on Clinical recovery and ejection fraction improvement. Aggressive immunosuppressive treatment with corticosteroids and cyclophosphamide led to clinical recovery and an increase in ejection fraction from 35% to 73% in a 34-year-old woman presenting with lupus myocarditis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: